跳至主要内容
临床试验/NCT02811237
NCT02811237已完成不适用

Criteria for Hospitalization or Outpatient Management of Patients With Pulmonary Embolism, Hestia Rule Versus Simplified PESI Score : an Open-label Controlled Randomized International Trial (HOME-PE)

University Hospital, Angers33 个研究点 分布在 5 个国家目标入组 1,975 人开始时间: 2017年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,975
试验地点
33
主要终点
The rate of the composite of recurrent VTE, major bleeding and all cause death at 30 days

研究概览

简要总结

Several studies have demonstrated the possibility of outpatient management or early discharge for certain patients presenting acute pulmonary embolism (PE), providing a suitable structure is in place.

The approach featured in the most recent guidelines on acute PE of the European Society of Cardiology, refers to an all-cause mortality risk assessment using the Pulmonary Embolism Severity Index (PESI) score or the simplified PESI score (sPESI). The sPESI takes into account demographics (age), patient history (cancer, cardiac or respiratory disease), and clinical data (systolic blood pressure, heart rate, oxygen saturation). Outpatient care is offered to low-risk patients, providing that all the conditions pertaining to start anticoagulant treatment and follow-up at home are met.

An alternative approach based on a list of simple criteria has been developed as the one used in HESTIA study. The main criteria included in the HESTIA rule consist of absence of the following: hemodynamic instability, need for oxygen therapy, high-risk of hemorrhage, renal or liver failure, or other medical or social conditions requiring hospitalization.

The investigators hereby propose comparing these two approaches in an open-label, controlled randomized international trial with blinded adjudication of endpoints.

The main objective is to demonstrate, in normotensive PE patients, that a strategy based on the HESTIA rule compared to a strategy based on the simplified PESI score is at least as safe as regards the 30-day-rate of adverse events (recurrent VTE, major bleeding or death).

The major secondary objectives are to demonstrate, in normotensive PE patients, that a strategy based on the HESTIA rule compared to a strategy based on the simplified PESI score is more effective :

  • As regards the rate of patients eventually managed as outpatients.
  • As regards the rate of patients, in theory, eligible for outpatient care,

详细描述

All patients admitted in the Emergency Department of the participating centres and diagnosed with PE will be eligible and assessed for potential inclusion.

Included patients will be randomized into two groups (1:1) and stratified by centre. Data will be recorded in a computerized case report form (e-CRF) enabling the randomization.

The HESTIA group will receive outpatient care proposal based on HESTIA criteria. The sPESI group will receive outpatient care proposal based on the simplified PESI score. Any reason for management (hospitalization or outpatient treatment) not based on the recommendation will be explained and documented in the e-CRF.

Follow-up will occur within 72 hours after inclusion, at 14 days, 1 month, and 3 months in both groups to gather clinical event data (recurrent VTE, major bleeding, death), treatment data, unscheduled hospitalizations and patient satisfaction assessment results.

The major objectives will test HESTIA based strategy versus sPESI based strategy in a hierarchical approach:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission to Emergency Department or unscheduled consultation in one of the participating centres;
  • Symptomatic pulmonary embolism objectively confirmed according to the European Society of Cardiology criteria
  • Insurance cover according to local legislation;
  • Age ≥18 years;
  • Free informed consent according to local legislation

排除标准

  • Shock or hypotension defined as systolic blood pressure <90 mmHg or a systolic pressure drop by ≥40 mmHg, for >15 minutes, if not caused by new-onset arrhythmia, hypovolaemia, or sepsis;
  • Diagnosis of pulmonary embolism established more than 24H before inclusion;
  • More than 48h between first presentation to the Emergency unit and inclusion - - Factors rendering 30-day follow-up impossible;

研究组 & 干预措施

HESTIA group

Other

干预措施: HESTIA (Other)

sPESI group

Other

干预措施: sPESI (Other)

结局指标

主要结局

The rate of the composite of recurrent VTE, major bleeding and all cause death at 30 days

时间窗: 30 days

* Recurrent VTE: objectively confirmed pulmonary embolism or deep venous thrombosis objectively confirmed. * Major bleeding: according to the International Society on Thrombosis and Haemostasis' criteria. * Death: all-cause mortality.

次要结局

  • The rate of "low-risk" patients in theory eligible for outpatient care (second major secondary objective)(1 day)
  • Safety endpoints - Death(14 days, 30 days, 90 days)
  • Applicability of management strategies(1 day)
  • Resources utilization(Day 90)
  • The rate of patients actually managed as outpatients (meaning patients discharged home within 24 hours after the inclusion in the study (first major secondary objective))(1 day)
  • Safety endpoints - Rate of cumulative events(14 days, 30 days, 90 days)
  • Safety endpoints - Recurrent VTE(14 days, 30 days, 90 days)
  • Safety endpoints - Suspected recurrent VTE(14 days, 30 days, 90 days)
  • Safety endpoints - Major Bleeding(14 days, 30 days, 90 days)
  • Safety endpoints - Non major bleeding(14 days, 30 days, 90 days)
  • Safety endpoints - Serious adverse event(14 days, 30 days, 90 days)
  • Patient satisfaction with care(30 days)
  • Patient quality of life(30 days)

研究者

发起方
University Hospital, Angers
申办方类型
Other Gov
责任方
Sponsor

研究点 (33)

Loading locations...

相似试验

撤回
不适用
Out-patient Discharge Management After General Intravenous AnesthesiaEvaluationOutpatient Surgery
NCT05609383Second Affiliated Hospital, School of Medicine, Zhejiang University
已完成
不适用
Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) PatientsMyocardial Infarction
NCT00474214Hamilton Health Sciences Corporation54
已完成
2 期
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive ChemotherapyAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Acute Myelomonocytic Leukemia (M4)Adult Erythroleukemia (M6a)Adult Pure Erythroid Leukemia (M6b)Previously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid Leukemia
NCT01235572Fred Hutchinson Cancer Center200
已完成
3 期
Hospitalization or Outpatient ManagEment of patients with Pulmonary Embolism: a randomized controlled trial - HOME-PE<br>
NL-OMON45665eids Universitair Medisch Centrum194
已完成
不适用
Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve ImplantationAortic Stenosis
NCT02404467Institut für Pharmakologie und Präventive Medizin502